Chronic Kidney Disease

PRINE Health IPA Partners With Empire Blue Cross Blue Shield

Empire Blue Cross Blue Shield has entered into an agreement with the PRINE Health Medical Group and PRINE Health IPA. The contracts are based on our commitment to Value-Based Kidney Care with our shared mission to:

  • Increase Home Dialysis
  • Facilitate more Kidney Transplantations
  • Improve Quality ESRD Starts outside the hospital setting with AV Fistuals
  • Lower overall cost
  • Improving the quality of care and Quality of Life for the advanced chronic kidney disease patient.

We look forward to developing this relationship further as we continue to build our infrastructure and capabilities toward providing an even better level of care for this important patient population.

For Nephrologists and complimentary physicians who take part in the care of Chronic Kidney Disease patients, please contact us to learn more about joining the IPA.

The Advances Of Telemedicine For CKD Patients

Telemedicine Milestones for CKD Patients

Over the last 12-24 months, we’ve seen legislatures and stakeholders in the Renal/Medical community place an increased emphasis on both telemedicine and home dialysis. As a result of the global pandemic, change and progress have been thrust upon patients and providers alike.

While the term ‘telemedicine’ sounds like an intimidating buzzword, all it means is an increased sense of safety and flexibility for patients, allowing them to be seen from the comfort of their own homes on a schedule that suits them best. No longer do patients have to worry about transportation to and from the doctor’s office, nor do they have to worry about additional safety measures from the virus. This is imperative for kidney failure patients who see a physician more often than other seniors. But we didn’t get here overnight. Below we will touch on milestones that laid the foundation for the rise of telemedicine for kidney disease patients.

 

Recent Events

One of the few objective successes of the President Trump era came in 2019 when he signed the Advancing American Kidney Health executive order, paving the way for an overhaul in the treatment process for end-stage renal disease patients. Not only did the President’s order shift resources towards Americans who have CKD and ESRD and how they’ll receive coverage from Medicare or Medicaid, but it also paved the way to make access easier for patients to receive organ transplants, telemedicine visits, and home dialysis.

In the United States, most patients receive dialysis for end-stage renal disease at a treatment facility, however, across the globe most patients receive their dialysis at home. However, there was a tangible shift in the last 12 months as a result of the pandemic

Home dialysis allowed patients to maintain safe social distancing protocols, while also allowing them to work from home and receive treatment on a schedule that best fits their needs. One of the top dialysis providers in the country reported a 25 percent increase in home dialysis training sessions in 2020 compared to the previous year, signaling that it could be the treatment option of the future.

The Shift to Home Dialysis for CKD Patients

Telemedicine also improves access to an accurate diagnosis and treatment plan for kidney disease patients in rural areas. Instead of requiring patients to drive multiple trips to a nearby hub where a provider and an accompanying dialysis treatment facility are located, now patients can schedule an appointment online, travel to a hub once to receive their access, and receive their treatment at home, allowing them to save time and money.

 

What the Future Holds

Home dialysis was undoubtedly a positive result for kidney disease patients, it wouldn’t be possible without telemedicine becoming more mainstream. By overcoming hurdles like ensuring that patients had access to the right technology, while also ensuring that HIPAA regulations were still being adhered to, there is an entirely new evolution in the way that physicians conduct instructional visits, and how patients receive care and treatment.

However, there are still obstacles to be overcome if telemedicine is going to be further streamlined into the mainstream of healthcare. For starters, high-speed internet access needs to be consistent across the board, otherwise, everything else is moot. Additionally, there needs to be somewhat of a regulatory overhaul in the way providers can practice across state lines. With the rise of telemedicine, we’re going to see a correlated rise in patients moving from their homes but still seeking treatment or diagnosis from a provider they are familiar with.

This is true with chronic illnesses such as kidney disease and diabetes, but also for mental illness and general counseling. With that reform, legislators and regulators should also consider the way that providers can prescribe medication via telemedicine and across certain state lines.

 

Conclusion

Regardless of whether it improves patient-to-provider dialogue and accessibility, or if it’s allowing one provider to relay previous findings to a specialist for a referral, the potential improvements that nephrology telemedicine has to the quality of life for healthcare patients are limitless. Because we’re only in the first few years of it becoming mainstream, the industry has only scratched the surface of the potential that telemedicine has.

Once insurance companies, regulators, and legislators get on board to make the process easier, experts expect to see telemedicine become the norm in both general practice and for specialists. If you have questions about how to transition to telemedicine or home dialysis, contact your nephrologist and ask them about the possibilities.

_____________

Susan Baker is a contributing author on behalf of InsuranceFAQ.net. Susan has been a freelance writer for five years and covers a wide array of topics ranging from Medicare insurance regulations to autoimmune disease health and wellness.

PRINE Vascular Press Release

FOR IMMEDIATE RELEASE: October 28, 2020

PRINE Health
370 Old Country Rd. Suite 100
Garden City, NY 11530

[email protected]

 

PRINE Health launches PRINE Vascular and Welcomes Dr. Dan Simon

PRINE Health is excited to announce its arrival into the Outpatient Vascular Lab space with the launch of PRINE Vascular!

Adding Dr. Dan Simon–a nationally recognized expert in the treatment of vascular disease–allows PRINE Health to venture into the outpatient surgery field of medicine with a focus on treating Peripheral Arterial Disease (PAD). This specific disease largely affects diabetic, hypertensive patients with known atherosclerosis. However, there is a strong albeit less well-known association with Chronic Kidney Disease (CKD). Studies show that up to one-third of patients with CKD may have underlying peripheral vascular disease. It is with that in mind that PRINE Health has moved forward with plans to create a unique vascular program with an emphasis on kidney patients. Thus, finding an expert on PAD treatment who has performed thousands of cases comes as a huge addition to the PRINE Health team.

Dr. Dan Simon, a board-certified interventional Radiologist, returns to New Hyde Park after having worked in various parts of the country (including Washington D.C., New Jersey, and California). Prior to getting into the outpatient field, Dr. Simon was co-chair of interventional Radiology at North Shore University Hospital (Northwell) in Manhasset, NY. As a native New Yorker, Dr. Simon is excited to return back home to Long Island with his wife and children.

“We are beyond thrilled to have Dr. Simon join us as Chief of PRINE Vascular as we kick off our first outpatient vascular lab,” said Dr. Simon Prince, CEO of PRINE Health. “We’re excited about the future. We believe our vascular ambitions complement our strategic focus on kidney care and will generate great value for our patients.”

 

PRINE Vascular Services:

  • PAD Treatment
  • Dialysis Access Management
  • Uterine Fibroid Embolization (UFE)
  • Kyphoplasty

All procedures are performed within the comfort of an outpatient setting, where patients can return home on the same day. Find out more at www.prinehealth.com/prine-vascular

 

ABOUT PRINE HEALTH

PRINE Health is a unique, multispecialty medical group focused on chronic kidney disease. PRINE launched last year with the merger of 6 independent nephrology groups to become the largest independent nephrology group in New York. In addition to the nephrologists, PRINE has added seasoned primary care physicians, podiatrists, and an interventional radiologist, and is involved in multiple ongoing conversations with other complementary specialties. There are currently 9 office locations and 18 dialysis center affiliations in Long Island and Queens.

PRINE also has a management company that is owned and governed by physicians. The MSO provides traditional practice management and population health services to the medical group. Over the last several months, PRINE has developed care management capabilities and several strategic relationships. PRINE has partnered with managed care payors and was recently selected by CMS to participate in a new value-based kidney care program, Kidney Care First in 2021.  Additionally, PRINE has partnered with data scientists to use predictive analytics and artificial intelligence on their growing patient population as efforts are being made to get ready to take risks in this complex, costly CKD/ESRD population.

To find out more about PRINE, visit www.prinehealth.com.

Book an Appointment